1
|
Ahmadnezhad M, Ghazizadeh H, Bijari M, Oladi MR, Esmaily H, Hoseini SJ, Barati E, Silakhori S, Mohammadi-Bajgiran M, Davari H, Parizadeh MR, Mokhber N, Sharifan P, Aref-Hosseini SR, Ferns GA, Moohebati M, Ghayour-Mobarhan M. Serum Pro-oxidant-antioxidant Balance in Subjects with Type 2 Diabetes Mellitus. Comb Chem High Throughput Screen 2020; 24:1476-1481. [PMID: 33155893 DOI: 10.2174/1386207323999201103203153] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2020] [Revised: 10/13/2020] [Accepted: 10/23/2020] [Indexed: 11/22/2022]
Abstract
AIM AND OBJECTIVE Diabetes mellitus is associated with inflammation and increased oxidative stress. In the current study, we aimed to investigate the relationship between type 2 diabetes mellitus (T2DM) and serum pro-oxidant-antioxidant balance (PAB) in a large populationbased study. METHODS In this cross-sectional study, 7888 individuals were recruited as part of the Mashhad Stroke and Heart Atherosclerotic Disorders (MASHAD) cohort study. Participants were divided into three groups based on their serum PAB values (levels < 36.4, 36.4-82.6 and > 82.6 HK). Serum PAB values were measured using a colorimetric method and enzyme-linked immune sorbent assay (ELISA). RESULTS Serum PAB in subjects with and without diabetes was reported 76.85 ± 61.07 HK and 69.51 ± 55.50 HK. In subjects with a serum PAB > 82.6 HK the risk of T2DM was 1.2 fold higher in comparison to subjects with a serum PAB < 36.4 HK (OR: 1.26, 95% CI: 1.09 - 1.47, P-value: 0.002). This association remained significant after adjustment for confounding factors in multivariable analysis (OR: 1.19, 95% CI: 1.02 - 1.38, P-value: 0.027). CONCLUSION Increased pro-oxidant levels may be a major complication of T2DM in our study subjects and PAB could be an indicator of higher oxidative stress in T2DM patients from northeastern Iran.
Collapse
Affiliation(s)
- Mahsa Ahmadnezhad
- Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Hamideh Ghazizadeh
- Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Moniba Bijari
- Metabolic syndrome Research center, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Mohammad Reza Oladi
- International UNESCO Center for Health- Related Basic Sciences and Human Nutrition, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Habibollah Esmaily
- Social Determinants of Health Research Center, Mashhad University of Medical sciences, Mashhad, Iran
| | - Seyed Javad Hoseini
- Metabolic syndrome Research center, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Elham Barati
- Metabolic syndrome Research center, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Samaneh Silakhori
- Metabolic syndrome Research center, Mashhad University of Medical Sciences, Mashhad, Iran
| | | | - Hafezeh Davari
- Metabolic syndrome Research center, Mashhad University of Medical Sciences, Mashhad, Iran
| | | | - Naghme Mokhber
- Department of Psychiatry, Faculty of Medicine & Psychiatric Research Centre, Ebn-sina Hospital, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Payam Sharifan
- Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran
| | | | - Gordon A Ferns
- Brighton & Sussex Medical School, Division of Medical Education, Falmer, Brighton, Sussex BN1 9PH, United Kingdom
| | - Mohsen Moohebati
- Cardiovascular Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Majid Ghayour-Mobarhan
- Metabolic syndrome Research center, Mashhad University of Medical Sciences, Mashhad, Iran
| |
Collapse
|